Rate My Professor Citra Praditi

In recognition of her contributions, Dr. Praditi received a three-year Post-Doctoral Fellowship valued at $300,000 from the Cancer Society of New Zealand in 2025, funded by the MJ Allen Estate. This award supports her project exploring ascorbate's enhancement of KDM activity to prevent genomic instability in melanoma, focusing on its role as a complementary therapy under hypoxic conditions using cell lines and clinical samples. Her key publications include: Praditi et al. (2025), "Iron content of glioblastoma tumours and role of ferrous iron in the hypoxic response in vitro," published in Frontiers in Oncology; Burgess et al. (2025), "Role of sodium-dependent vitamin C transporter-2 and ascorbate in regulating the hypoxic pathway in cultured glioblastoma cells," in the Journal of Cellular Biochemistry, where she is a joint first author; and Praditi et al. (2023), "Ascorbate Uptake and Retention by Breast Cancer Cell Lines and the Intracellular Distribution of Sodium-Dependent Vitamin C Transporter 2," in Antioxidants. She also contributed a conference abstract at the New Zealand Society for Biochemistry and Molecular Biology 50th Anniversary Conference in 2023 on ascorbate's activation of hypoxic responses in breast cancer cells. Through these efforts, Praditi advances understanding of ascorbate's potential in cancer therapies.